Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer metformin myeloid leukemia burn scars marjolin's ulcer

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	New prostate cancer test cuts biopsies by 50% in US - 26 days ago MHRA grants approval for bladder cancer drug erdafitinib - 3 months ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - 4 months ago
2	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Circumventing Cancer Resistance - about 1 month ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests - 3 months ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 months ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 9 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 10 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 10 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - about 1 year ago Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone - about 1 year ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - about 1 year ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - about 1 year ago TULSA Effective in Controlling Prostate Cancer Long-Term - about 1 year ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - about 1 year ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - about 1 year ago Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - over 1 year ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study - 5 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - over 1 year ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - over 1 year ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 months ago Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC With Adagrasib - 10 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 8 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novartis Pays $150M to Nab a Phase 3-Ready Protein Degrader for Prostate Cancer - 10 months ago
8	AFP Science Alert Science news. Official account. Australia science news	Scientists Predict Prostate Cancer Cases to Double Within 20 Years - 10 months ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC - 11 months ago Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies - 12 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - about 1 year ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - about 1 year ago New Capivasertib Approval Benefits Patients With Breast Cancer, PIK3CA/AKT1/PTEN Alterations - about 1 year ago

Journalists covering castrate-resistant prostate cancer